Navigation

Kliniske forsøg

Clinical Trial Biostatistics and Biopharmaceutical Applications

Udgivet af Taylor & Francis Ltd

Bogdetaljer

  • Hæftet
  • 580 sider
  • Engelsk
ISBN 9780367576035
Om denne bog

Since 1945, "The Annual Deming Conference on Applied Statistics" has been an important event in the statistics profession. In Clinical Trial Biostatistics and Biopharmaceutical Applications, prominent speakers from past Deming conferences present novel biostatistical methodologies in clinical trials as well as up-to-da…

Se alle bogdetaljer →
Prissammenligning

Ingen boghandelspriser listet endnu

Denne titel er i vores bogkatalog. Butikstilbud vises her, når de er tilgængelige.

Betroet sælger:

Ingen boghandelstilbud lige nu.

Søg efter ISBN
Opdateret i dag

Boghandelspriser

Boghandel Titel Format ISBN Pris Lagerstatus Levering

Ingen boghandelstilbud endnu

Vi har titlen i kataloget. Priser vises her, når boghandlere lister den.

0.0
0 anmeldelser
5
0
4
0
3
0
2
0
1
0
0%
Anbefaler
0
Verificeret
Alle anmeldelser (0)

Ingen anmeldelser endnu

Skriv en anmeldelse

Valgfri - Kun brugt til verifikation
0 / 5000 tegn
Bogdetaljer
Forlag Taylor & Francis Ltd
Kategori Kliniske forsøg
ISBN-13 9780367576035
EAN 9780367576035
Format Hæftet
Sprog Engelsk
sider 580
Produktbeskrivelse
Since 1945, "The Annual Deming Conference on Applied Statistics" has been an important event in the statistics profession. In Clinical Trial Biostatistics and Biopharmaceutical Applications, prominent speakers from past Deming conferences present novel biostatistical methodologies in clinical trials as well as up-to-date biostatistical applications from the pharmaceutical industry.Divided into five sections, the book begins with emerging issues in clinical trial design and analysis, including the roles of modeling and simulation, the pros and cons of randomization procedures, the design of Phase II dose-ranging trials, thorough QT/QTc clinical trials, and assay sensitivity and the constancy assumption in noninferiority trials. The second section examines adaptive designs in drug development, discusses the consequences of group-sequential and adaptive designs, and illustrates group sequential design in R. The third section focuses on oncology clinical trials, covering competing risks, escalation with overdose control (EWOC) dose finding, and interval-censored time-to-event data. In the fourth section, the book describes multiple test problems with applications to adaptive designs, graphical approaches to multiple testing, the estimation of simultaneous confidence intervals for multiple comparisons, and weighted parametric multiple testing methods. The final section discusses the statistical analysis of biomarkers from omics technologies, biomarker strategies applicable to clinical development, and the statistical evaluation of surrogate endpoints.This book clarifies important issues when designing and analyzing clinical trials, including several misunderstood and unresolved challenges. It will help readers choose the right method for their biostatistical application. Each chapter is self-contained with references.

Prishistorik

Indlæser prishistorik...

Få prisalarm

Bliv underrettet, når prisen falder til dit ønskede beløb.